Advertisement
Screener

VolitionRx Limited (VNRX) Preferred Stock, Par or Stated Value Per Share

2.8 / 5 stars · 68/120 Roast Me

VolitionRx Limited Preferred Stock, Par or Stated Value Per Share

VolitionRx Limited (VNRX) had Preferred Stock, Par or Stated Value Per Share of $0.00 per share as of 2016-10-07, per its 10-K filed 2017-03-10.

Discontinued › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure

us-gaap:PreferredStockParOrStatedValuePerShare · last filed 2017-03-10

  • 2016-10-07: Preferred Stock, Par or Stated Value Per Share $0.00.
  • 2016-06-30: Preferred Stock, Par or Stated Value Per Share $0.00.
  • 2016-03-31: Preferred Stock, Par or Stated Value Per Share $0.00.
  • 2015-12-31: Preferred Stock, Par or Stated Value Per Share $0.00.
Period endPreferred Stock, Par or Stated Value Per Share
2016-10-07$0.00
10-K · filed 2017-03-10
2016-06-30$0.00
10-Q · filed 2016-08-11
2016-03-31$0.00
10-Q · filed 2016-05-13
2015-12-31$0.00
10-Q · filed 2016-08-11
2015-09-30$0.00
10-Q · filed 2015-11-04
2015-06-30$0.00
10-Q · filed 2015-08-11
2015-03-31$0.00
10-Q · filed 2015-05-12
2014-12-31$0.00
10-K · filed 2016-03-11
2014-09-30$0.00
10-Q · filed 2014-11-06
2014-06-30$0.00
10-Q · filed 2014-08-01
2014-03-31$0.00
10-Q · filed 2014-05-15
2013-12-31$0.00
10-K · filed 2015-03-18
2013-09-30$0.00
10-Q · filed 2013-10-31
2012-12-31$0.00
10-K · filed 2014-03-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
BIOMERICA INC (BMRA)United States$0.011B
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92